The platform surpasses 1,100 clinics and 900,000 patients, delivering up to 80% reduction in processing time. SAN FRANCISCO, Jan. 7,…
BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The…
The platform surpasses 1,100 clinics and 900,000 patients, delivering up to 80% reduction in processing time. SAN FRANCISCO, Jan. 7,…
BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The…
BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The…
SAN MATEO, Calif., Jan. 7, 2026 /PRNewswire/ -- Notable, the leading healthcare AI platform for transforming workforce productivity, today announced…
SAN MATEO, Calif., Jan. 7, 2026 /PRNewswire/ -- Notable, the leading healthcare AI platform for transforming workforce productivity, today announced…
Formal written minutes from the U.S. FDA confirms no major concerns identified for the planned Phase 3 PANDA study of…
CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (Nasdaq: GEHC) (“GE HealthCare”) announced today that it received notice on January 5, 2026, of…
Leading provider of AI-driven virtual care solutionsLOS ANGELES, Jan. 6, 2026 /PRNewswire/ -- Brown Gibbons Lang & Company (BGL), a…